These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30895596)

  • 1. Comparing the performance of gene expression assays in breast cancer.
    Suthers GK
    Int J Cancer; 2019 Aug; 145(4):1162. PubMed ID: 30895596
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's reply to: Comparing the performance of gene expression assays in breast cancer.
    Varga Z; Sinn P; Seidman AD
    Int J Cancer; 2019 Aug; 145(4):1163-1164. PubMed ID: 30895601
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evidence supporting genomic tests in early breast cancer: Do all genomic tests provide the same information?
    Markopoulos C; van de Velde C; Zarca D; Ozmen V; Masetti R
    Eur J Surg Oncol; 2017 May; 43(5):909-920. PubMed ID: 27639633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multigene assays for late recurrence of breast cancer.
    Ignatiadis M
    Lancet Oncol; 2013 Oct; 14(11):1029-1030. PubMed ID: 24035533
    [No Abstract]   [Full Text] [Related]  

  • 5. Gene-expression-based predictors for breast cancer.
    Goetz MP; Ingle JN; Couch FJ
    N Engl J Med; 2007 Feb; 356(7):752; author reply 752-3. PubMed ID: 17301312
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene expression profiling in breast cancer.
    Nasser SM
    J Med Liban; 2009; 57(2):83-8. PubMed ID: 19623883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making.
    Sparano JA; Solin LJ
    J Clin Oncol; 2010 Apr; 28(10):1625-7. PubMed ID: 20065178
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene-expression assays: new tools to individualize treatment of early-stage breast cancer.
    Dobbe E; Gurney K; Kiekow S; Lafferty JS; Kolesar JM
    Am J Health Syst Pharm; 2008 Jan; 65(1):23-8. PubMed ID: 18159035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
    Kreike B; Halfwerk H; Kristel P; Glas A; Peterse H; Bartelink H; van de Vijver MJ
    Clin Cancer Res; 2006 Oct; 12(19):5705-12. PubMed ID: 17020974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene-Expression-Based Predictors for Breast Cancer.
    Gupta A; Mutebi M; Bardia A
    Ann Surg Oncol; 2015 Oct; 22(11):3418-32. PubMed ID: 26215189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer molecular subtypes in patients with locally advanced disease: impact on prognosis, patterns of recurrence, and response to therapy.
    Huber KE; Carey LA; Wazer DE
    Semin Radiat Oncol; 2009 Oct; 19(4):204-10. PubMed ID: 19732684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-expression profiling and identification of patients at high risk of breast cancer.
    Palmieri C; Vigushin D
    Lancet; 2002 Jul; 360(9327):173; author reply 174. PubMed ID: 12126851
    [No Abstract]   [Full Text] [Related]  

  • 13. Population-based molecular prognosis of breast cancer by transcriptional profiling.
    Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
    Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer: The 21-gene recurrence score - biology remains at the forefront.
    Puhalla SL; Davidson NE
    Nat Rev Clin Oncol; 2016 Aug; 13(8):470-2. PubMed ID: 27296295
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene profiling coming of age in cancer therapy.
    Johns Hopkins Med Lett Health After 50; 2005 Jun; 17(4):4-6. PubMed ID: 15962414
    [No Abstract]   [Full Text] [Related]  

  • 16. MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.
    Li H; Zhu Y; Burnside ES; Drukker K; Hoadley KA; Fan C; Conzen SD; Whitman GJ; Sutton EJ; Net JM; Ganott M; Huang E; Morris EA; Perou CM; Ji Y; Giger ML
    Radiology; 2016 Nov; 281(2):382-391. PubMed ID: 27144536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of breast cancer to select women for adjuvant chemotherapy.
    Technol Eval Cent Assess Program Exec Summ; 2008 Apr; 22(13):1-8. PubMed ID: 18663816
    [No Abstract]   [Full Text] [Related]  

  • 18. The 21-gene recurrence score assay in node-negative early breast cancer: Prognostic, predictive or presumptuous?
    Jerzak KJ; Pritchard KI
    Eur J Cancer; 2016 Nov; 68():173-175. PubMed ID: 27768924
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomics and challenges toward personalized breast cancer local control.
    Roukos DH; Lykoudis E; Liakakos T
    J Clin Oncol; 2008 Sep; 26(26):4360-1; author reply 4361-2. PubMed ID: 18779627
    [No Abstract]   [Full Text] [Related]  

  • 20. Initial experience with genomic profiling of heavily pretreated breast cancers.
    Staren ED; Braun D; Tan B; Gupta D; Kim S; Kramer K; Markman M
    Ann Surg Oncol; 2014 Oct; 21(10):3216-22. PubMed ID: 25047475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.